First Horizon Corporation’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.29K Sell
636
-2,224
-78% -$29.4K ﹤0.01% 1138
2026
Q1
$39.4K Sell
2,860
-31
-1% -$467 ﹤0.01% 691
2025
Q4
$52.1K Buy
2,891
+2,337
+422% +$42K ﹤0.01% 655
2025
Q3
$10.3K Buy
+554
New +$8.7K ﹤0.01% 1064

Other funds holding CLBT

First Horizon Corporation's CLBT Position: Q2 2026 in Review

First Horizon Corporation reduced its Cellebrite (CLBT) stake by 78% in Q2 2026, selling an estimated $29.4K and leaving 636 shares worth $9.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

First Horizon Corporation first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $52.1K in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • First Horizon Corporation held 636 shares of Cellebrite worth $9.29K as of Q2 2026.
  • First Horizon Corporation sold 2,224 Cellebrite shares in Q2 2026, an estimated $29.4K.
  • Cellebrite made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1138 holding.
  • First Horizon Corporation first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Cellebrite position peaked at $52.1K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.